Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population

Stroke

Volumn 31, Issue 6, 2000, Pages 1299-1306

  Kokubo, Yoshihiro ^a,b   Chowdhury, Anisul Haque ^b   Date, Chigusa ^c   Yokoyama, Tetsuji ^b   Sobue, Hatiki ^d   Tanaka, Heizo ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b Osaka City University Medical School ^*  (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d Hokuetsu Hospital   (Japan)

Author keywords

Apolipoproteins; Genetics; Japan; Stroke classification

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; AGING; ARTICLE; BRAIN HEMORRHAGE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENOTYPE; HIGH RISK POPULATION; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RURAL POPULATION; STROKE;

EID: 0034075368     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.6.1299     Document Type: Article

References (60)

1. Tanaka H, Yokoyama T. Cerebrovascular disease. In: Detels R, Holland WW, eds. Oxford Textbook of Public Health. 3rd ed. Oxford, UK: Oxford University Press; 1997:1065-1079.
2. Stegmayr B, Asplund K, Kuulasmaa K, Rajakangas AM, Thorvaldsen P, Tuomilehto J. Stroke incidence and mortality correlated to stroke risk factors in the WHO MONICA Project: an ecological study of 18 populations. Stroke. 1997;28:1367-1374.
3. Tanaka H, Ueda Y, Hayashi M, Date C, Baba T, Yamashita H, Shoji H, Tanaka Y, Owada K, Detels R. Risk factors for cerebral hemorrhage and cerebral infarction in a Japanese rural community. Stroke. 1982;13:62-73.
4. Hillbom M, Kaste M. Alcohol intoxication: a risk factor for primary subarachnoid hemorrhage. Neurology. 1982;32:706-711.
5. Gill JS, Zezulka AV, Shipley MJ, Gill SK, Beevers DG. Stroke and alcohol consumption. N Engl J Med. 1986;315:1041-1046.
6. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ. 1989;298:789-794.
7. Iso H, Jacobs DR Jr, Wentworth D, Neaton JD, Cohen JD. Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the Multiple Risk Factor Intervention Trial. N Engl J Med. 1989;320:904-910.
8. Okada H, Horibe H, Yoshiyuki O, Hayakawa N, Aoki N. A prospective study of cerebrovascular disease in Japanese rural communities, Akabane and Asahi, 1: evaluation of risk factors in the occurrence of cerebral hemorrhage and thrombosis. Stroke. 1976;7:599-607.
9. Ueshima H, Iida M, Shimamoto T, Konishi M, Tsujioka K, Tanigaki M, Nakanishi N, Ozawa H, Kojima S, Komachi Y. Multivariate analysis of risk factors for stroke: eight-year follow-up study of farming villages in Akita, Japan. Prey Med. 1980;9:722-740.
10. Zaman MM, Ikemoto S, Yoshiike N, Date C, Yokoyama T, Tanaka H. Association of apolipoprotein genetic polymorphisms with plasma cholesterol in a Japanese rural population: the Shibata Study. Arterioscler Thromb Vasc Biol. 1997;17:3495-3504.
11. Utermann G, Hees M, Steinmetz A. Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature. 1977;269: 604-607.
12. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1-21.
13. Sing CF, Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet. 1985;37:268-285.
14. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468-471.
15. Couderc R, Mahieux F, Bailleul S, Fenelon G, Mary R, Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease: a case-control study. Stroke. 1993;24:661-664.
16. Pedro-Botet J, Senti M, Nogues X, Rubies-Prat J, Roquer J, D'Olhaberriague L, Olive J. Lipoprotein and apolipoprotein profile in men with ischemic stroke: role of lipoprotein(a). triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke. 1992;23: 1556-1562.
17. Margaglione M, Seripa D, Gravina C, Grandone E, Vecchione G, Cappucci G, Merla G, Papa S, Postiglione A, Di Minno G, Fazio VM. Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian case-control study. Stroke. 1998;29:399-403.
18. Peng DQ, Zhao SP, Wang JL. Lipoprotein (a), and apolipoprotein E ∈4 as independent risk factors for ischemic stroke. J Cardiovasc Risk. 1999; 6:1-6.
19. Kessler C, Spitzer C, Stauske D, Mende S, Stadlmuller J, Walther R, Rettig R. The apolipoprotein E and β-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol. 1997;17:2880-2884.
20. Mahieux S, Bailleul S, Fenelon G, Couderc R, Laruelle P, Guillard A. Prevalence of apolipoprotein E phenotypes in patients with acute ischemic stroke. Stroke. 1990;21:115. Abstract.
21. Coria F, Rubio I, Nunez E, Sempere AP, SantaEngarcia N, Bayon C, Cuadrado N. Apolipoprotein E variants in ischemic stroke. Stroke. 1995; 26:2375-2376. Letter.
22. Hachinski V, Graffagnino C, Beaudry M, Bernier G, Buck C, Donner A, Spence JD, Doig G, Wolfe BM. Lipids and stroke: a paradox resolved. Arch Neurol. 1996;53:303-308.
23. Nakata Y, Katsuya T, Rakugi H, Takami S, Sato N, Kamide K, Ohishi M, Miki T, Higaki J, Ogihara T. Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. Am J Hypertens. 1997;10: 1391-1395.
24. Ferrucci L, Guralnik JM, Pahor M, Harris T, Corti MC, Hyman BT, Wallace RB, Havlik RJ. Apolipoprotein E ∈2 allele and risk of stroke in the older population. Stroke. 1997;28:2410-2416.
25. Kuusisto J, Mykkanen L, Kervinen K, Kesaniemi YA, Laakso M. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol. 1995;15:1280-1286.
26. Basun H, Corder EH, Guo Z, Lannfelt L, Corder LS, Manton KG, Winblad B, Viitanen M. Apolipoprotein E polymorphism and stroke in a population sample aged 75 years or more. Stroke. 1996;27:1310-1315.
27. Special report from the National Institute of Neurological Disorders and Stroke: classification of cerebrovascular diseases III. Stroke. 1990;21: 637-676.
28. Millikan C, Futrell N. The fallacy of the lacune hypothesis. Stroke. 1990;21:1251-1257.
29. Baba T, Tanaka H, Date C, Hayashi M, Tanaka Y, Okazaki K, Nakamura M, Iida M, Komachi Y, Yoshikawa K, Horimoto T, Shimada T, Yamamoto H, Owada K. The standardization of measurement of lipids for epidemiologic study of stroke. Jpn J Hyg. 1983;38:606-613.
30. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res. 1990;31: 545-548.
31. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
32. Schachter F, Faure-Delanef L, Guenot F, Rouger H, Froguel P, Lesueur-Ginot L, Cohen D. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994;6:29-32.
33. Figueiras A, Domenech-Massons JM, Cadarso C. Regression models: calculating the confidence interval of effects in the presence of interactions. Stat Med. 1998;17:2099-2105.
34. Report of the Joint Committee for Stroke Facilities, I: epidemiology for stroke facilities planning. Stroke. 1972;3:359-371.
35. Ooneda G, Yoshida Y, Suzuki K, Shinkai H, Hori S, Kobori K, Takayama Y, Sekiguchi M. Smooth muscle cells in the development of plasmatic arterionecrosis, arteriosclerosis, and arterial contraction. Blood Vessels. 1978;15:148-156.
36. Reed DM. The paradox of high risk of stroke in populations with low risk of coronary heart disease. Am J Epidemiol. 1990;131:579-588.
37. Takeya Y, Popper JS, Shimizu Y, Kato H, Rhoads GG, Kagan A. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: incidence of stroke in Japan and Hawaii. Stroke. 1984;15:15-23.
38. Aull S, Lalouschek W, Schnider P, Sinzinger H, Uhl F, Zeiler K. Dynamic changes of plasma lipids and lipoproteins in patients after transient ischemic attack or minor stroke. Am J Med. 1996;101:291-298.
39. Cooper GR, Myers GL, Smith SJ, Schlant RC. Blood lipid measurements: variations and practical utility. JAMA. 1992;267:1652-1660.
40. Brewer HB Jr, Zech LA, Gregg RE, Schwartz D, Schaefer EJ. NIH conference: type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment. Ann Intern Med. 1983;98:623-640.
41. Gregg RE, Zech LA, Schaefer EJ, Brewer HB Jr. Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E. Science. 1981;211:584-586.
42. Gregg RE, Zech LA, Schaefer EJ, Stark D, Wilson D, Brewer HB Jr. Abnormal in vivo metabolism of apolipoprotein E4 in humans. J Clin Invest. 1986;78:815-821.
43. de Andrade M, Thandi I, Brown S, Gotto A Jr, Patsch W, Boerwinkle E. Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis. Am J Hum Genet. 1995;56:1379-1390.
44. Fiol C, Pinto X, Santamaria P, Simeon J, Capdevila J. Anomalous apoprotein E isoforms in peripheral arteriopathy. Clin Chem. 1987;33:471. Abstract.
45. Weisgraber KH, Innerarity TL, Mahley RW. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem. 1982;257:2518-2521.
46. Hixson JE. Apolipoprotein E polymorphisms affect atherosclerosis in young males: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Arterioscler Thromb. 1991;11:1237-1244.
47. Wang XL, MeCredie RM, Wilcken DE. Polymorphisms of the apolipoprotein E gene and severity of coronary artery disease defined by angiography. Arterioscler Thromb Vasc Biol. 1995;15:1030-1034.
48. van Bockxmeer FM. Apolipoprotein E and Alzheimer's. Nature. 1995; 375:285. Letter.
49. Slooter AJ, Tang MX, van Duijn CM, Stern Y, Ott A, Bell K, Breteler MM, Van Broeckhoven C, Tatemichi TK, Tycko B, Hofman A, Mayeux R. Apolipoprotein E ∈4 and the risk of dementia with stroke: a population-based investigation. JAMA. 1997;277:818-821.
50. Seino F, Date C, Nakayama T, Yoshiike N, Yokoyama T, Yamaguchi M, Tanaka H. Dietary lipids and incidence of cerebral infarction in a Japanese rural community. J Nutr Sci Vitaminol. 1997;43:83-99.
51. Jarvik GP, Austin MA, Fabsitz RR, Auwerx J, Reed T, Christian JC, Deeb S. Genetic influences on age-related change in total cholesterol, low density lipoprotein-cholesterol, and triglyceride levels: longitudinal apolipoprotein E genotype effects. Genet Epidemiol. 1994;11:375-384.
52. Caplan LR, Gorelick PB, Hier DB. Race, sex and occlusive cerebrovascular disease: a review. Stroke. 1986;17:648-655.
53. Mathew NT, Davis D, Meyer JS, Chandar K. Hyperlipoproteinemia in occlusive cerebrovascular disease. JAMA. 1975;232:262-266.
54. Vogel RA, Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol. 1997;79:350-354.
55. Plotnick GD, Corretti MC, Vogel RA. Effect of antioxidant vitamins on the transient impairment of endothelium-dependent brachial artery vaso-activity following a single high-fat meal. JAMA. 1997;278:1682-1686.
56. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 1993;91: 2546-2551.
57. Shiode N, Nakayama K, Morishima N, Yamagata T, Matsuura H, Kajiyama G. Nitric oxide production by coronary conductance and resistance vessels in hypercholesterolemia patients. Am Heart J. 1996; 131:1051-1057.
58. Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT. Apolipoprotein E ∈4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol. 1995;38:254-259.
59. Greenberg SM, Vonsattel JP, Segal AZ, Chiu RI, Clatworthy AE, Liao A, Hyman BT, Rebeck GW. Association of apolipoprotein E ∈2 and vasculopathy in cerebral amyloid angiopathy. Neurology. 1998;50: 961-965.
60. O'Donnell HC, Rosand J, Knudsen KA, Furie KL, Segal AZ, Chiu RI, Ikeda D, Greenberg SM. Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med. 2000;342: 240-245.